TNFRSF8 and lymphoma: This study aims to address this gap by collecting data from real-world outcomes and management in routine clinical practice in Spain by evaluating the effectiveness and safety of BV retreatment in a cohort of Spanish patients with relapsed/refractory CD30-positive lymphomas.